Quest hits 3-year high after beating quarterly results estimates
** Shares of lab operator Quest Diagnostics DGX.N rise as
much as 7% to an over three-year high of $166.39
** Co's Q4 adj EPS of $2.23 beats Wall Street estimates of
$2.19 - data compiled by LSEG
** DGX's Q4 revenue of $2.62 bln is above estimates of $2.58
bln
** Co expects 2025 revenue between $10.70 and $10.85 bln,
above estimates of $10.67 bln
** Shares of peer Labcorp LH.N up 4.8%
** DGX shares rose 9.4% in 2024
(Reporting by Puyaan Singh)
((Puyaan.Singh@thomsonreuters.com;))
Recent news on Labcorp Holdings
See all newsBrief: Charles River, Labcorp, And FDA Collaborate To Validate New Preclinical Methods For Abuse Potential Assessment
Brief: Labcorp Declares Quarterly Dividend
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
Live Markets: Split US congress after 2026 midterms could boost healthcare stocks, Mizuho says